Fig. 3From: Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experimentsKM curve for SYTL1 in all tumor patients. A-G, subgroup analysis for Stage I&Stage II, Stage III&Stage IV, G1, G2, G3, tumor invasion < 50% and tumor invasion > = 50%Back to article page